The device company’s orthopedic reconstructive business and extremities business totaled $59.5 million and $50.9 million, respectively. These totals represent a 12.2 percent loss and a 0.8 percent gain, respectively.
More Articles on Orthopedic Devices:
Alphatec Spine 3Q Revenue Drops 1.6%
